Satellos Bioscience Inc.
MSCL
Kedudukan dalam Saham
#17768
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Harga Saham
$10.22
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$212.97M
Perubahan (1 hari)
4.58%
Perubahan (1 tahun)
2,278.10%
Negara
CA
Perdagangan Satellos Bioscience Inc. (MSCL)
Kategori
Healthcare
Sejarah harga saham bagi Satellos Bioscience Inc. (MSCL)
Harga penutupan tertinggi: $0.48 pada 2024-03-01
Harga penutupan terendah: $12.71 pada 2008-01-01
Harga penutupan terendah: $12.71 pada 2008-01-01
Sejarah harga saham Satellos Bioscience Inc. dari 2008 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2024 | 43.42% |
| 2023 | 91.27% |
| 2022 | -80.10% |
| 2021 | 2.79% |
| 2020 | -11.41% |
| 2019 | 10.94% |
| 2018 | 37.66% |
| 2017 | -27.41% |
| 2016 | 41.02% |
| 2015 | -8.55% |
| 2014 | -90.26% |
| 2013 | -52.35% |
| 2012 | 195.82% |
| 2011 | -36.68% |
| 2010 | -30.40% |
| 2009 | 333.63% |
| 2008 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
